BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld
BioWorld
April 30, 2010
View Archived Issues
Well-Timed Wnt Can Speed Bone Healing After Injury
Read More
CEO Stepping Down as Celgene Beats Estimates, Plans Growth
Read More
Corrections & Clarifications
Read More
Affimed Plans to Take Antibodies into Clinic with $26M Series C
Read More
Clinic Roundup
Read More
Stock Movers
Read More
Other News To Note
Read More
FDA Clears Provenge; Up Next: Fast Launch, Slow Ramp
Dendreon Corp. made history on Thursday, securing a long sought-after FDA approval for prostate cancer vaccine Provenge (sipuleucel-T). (BioWorld Today)
Read More
HCV Specialist Idenix Raising $26.2M in Stock Offering
Read More